PetMed Express, Inc. (NASDAQ:PETS) Closed 21.1% Above Its 50 Day Moving Average


Shares last traded at $43.41 significantly higher than $35.86, the stock’s 50 day moving average and which is quite a bit higher than the 200 day moving average of $36.30. The 50 day moving average went up $7.55 or +21.06% and the 200 day average went up $7.11 or +19.60%. PetMed Express, Inc. shares had a trading volume of 1,151K in the last trading session. Volume was up 130.60% over the stocks average daily volume.

Traders are more bullish on the company as implied by the change in short interest. The firm realized a fall in short interest between September 15, 2017 and September 29, 2017 of -10.37%. Short shares decreased from 6,852,102 to 6,141,504 over that period. With short interest at 6,141,504 and short average daily volume at 937,264, the short-interest ratio is 7.0 and the percentage of shorted shares is 0.30% as of September 29.

These firms have modified their investment in PETS. Fisher Asset Management, LLC expanded its investment by buying 5,476 shares an increase of 4.5% as of 09/30/2017. Fisher Asset Management, LLC currently owns 126,797 shares worth $4,203,000. The value of the position overall is down by 14.7%. Meeder Asset Management Inc reduced its holdings by selling 102 shares a decrease of 81.6% in the quarter. Meeder Asset Management Inc controls 23 shares valued at $1,000. The total value of its holdings decreased 80.0%.

Bank Of Montreal /can/ grew its position by buying 93 shares an increase of 14.4% from 06/30/2017 to 09/30/2017. Bank Of Montreal /can/ owns 740 shares with a value of $25,000. The total value of its holdings decreased 3.8%. As of the end of the quarter Capital One, National Association had acquired 107 shares growing its position 0.3%. The value of the investment in (PETS) decreased from $1,280,000 to $1,049,000 decreasing 18.0% quarter over quarter.

On July 11, 2017 the stock rating was set at “Hold” by Craig-Hallum which is down from the previous “Hold” rating. On July 24 the company was upgraded from “Neutral” to “Buy” in a statement from Northcoast Research.

PetMed Express, Inc.’s P/E ratio is 33.39 and the market cap is 880.88M. As of the latest earnings report the EPS was $1.30 and is projected to be $1.44 for the current year with 20,292,000 shares outstanding. Analysts expect next quarter’s EPS will be $0.29 and the next full year EPS is anticipated to be $1.58.

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, launched on January 3, 1997, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company offers a selection of products for dogs and cats. The Business’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies..